Uni-Bio Science Group Limited — Capital/Financing Update 2017

Sep 20, 2017

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [25 x 25] intentionally omitted <==

==> picture [31 x 37] intentionally omitted <==

==> picture [24 x 29] intentionally omitted <==

==> picture [117 x 50] intentionally omitted <==

UNI-BIO SCIENCE GROUP LIMITED 聯康生物科技集團有限公司*

(Incorporated in the Cayman Islands with limited liability) (Stock code: 0690)

COMPLETION OF ISSUE OF SHARES AND ISSUE OF UNLISTED WARRANTS UNDER SPECIFIC MANDATE

Reference is made to the circular of Uni-Bio Science Group Limited (“ Company ”) dated 24 August 2017 (“ Circular ”) and the poll results announcement of the Company dated 11 September 2017 in relation to, among other things, the Subscriptions and the Warrants. Unless otherwise defined, terms used in this announcement shall have the same meaning as defined in the Circular.

The Board is pleased to announce that all the conditions precedent to the Subscriptions have been fulfilled and the Completion took place on 20 September 2017 in accordance with the terms and conditions of the Subscription Agreements. Pursuant to the Subscription Agreements, the Company allotted and issued a total of 1,027,480,000 Subscription Shares to the Subscribers at the issue price of HK$0.138 per Subscription Share.

Upon Completion, all the conditions to the issue of the Warrants have been fulfilled and the Warrant Closing took place on 20 September 2017 immediately after Completion in accordance with the terms and conditions of the Subscription Agreements. Warrants conferring the rights to the holders thereof to subscribe up to HK$52,992,281 in aggregate for the Warrant Shares were issued by the Company to the Subscribers.

• For identification purpose only

1

The shareholding structure of the Company (i) immediately before Completion; (ii) immediately after Completion; and (iii) immediately after the exercise in full of the Warrant Subscription Rights attached to the Warrants at the initial subscription price of HK$0.2063 per Warrant Share (assuming that there is no other change the issued share capital of the Company) are as follows:

ShareholdersAutomatic Result Limited(Note 1)Lord Profit Limited(Note 2)Overseas Capital Assets Limited(Note 3)Mr. Chen Dawei (Note 4)Subscriber ASubscriber BOther ShareholdersTotal	(1) Immediately beforeCompletionNumber ofShares%616,301,01612.00914,576,01617.80 657,180,00012.79315,955,5166.15––––2,633,475,59951.265,137,488,147100.00	(2) Immediately afterCompletionNumber ofShares%616,301,01610.00914,576,01614.83657,180,00010.66315,955,5165.12873,360,00014.17154,120,0002.502,633,475,59942.726,164,968,147100.00	(3) Immediately after theexercise of the WarrantSubscription Rights in fullNumber ofShares%616,301,0169.60914,576,01614.24657,180,00010.23315,955,5164.921,091,700,00017.00192,650,0003.002,633,475,59941.016,421,838,147100.00	(3) Immediately after theexercise of the WarrantSubscription Rights in fullNumber ofShares%616,301,0169.60914,576,01614.24657,180,00010.23315,955,5164.921,091,700,00017.00192,650,0003.002,633,475,59941.016,421,838,147100.00
				100.00

Notes:

1. Automatic Result Limited is wholly owned by MJKPC Holdings Limited, which is a family trust which Mr. Kingsley Leung is one of the discretionary objects.

2. Lord Profit Limited is wholly owned by Mr. Kingsley Leung, an executive Director and chairman of the Board.

• Based on the notice of disclosure of interest of Overseas Capital Assets Limited dated 19 June 2014.

1. Mr. Chen Dawei is an executive Director and vice chairman of the Board. The above does not take into account the Shares which may be issued to Mr. Chen Dawei pursuant to the terms of the executive director service contract dated 13 January 2017 entered into between the Company and Mr. Chen Dawei in relation to the appointment of Mr. Chen Dawei as an executive Director, further particulars of which are set out in the circular of the Company dated 8 June 2017.

2. Certain percentage figures included in the above tables have been subject to rounding adjustments. Accordingly, figures shown as totals may not be an arithmetic aggregation of the figures preceding them.

On behalf of the Board Uni-Bio Science Group Limited Kingsley Leung Chairman

Hong Kong, 20 September 2017

As at the date of this announcement, the Board comprises two executive Directors, namely, Mr. Kingsley Leung (Chairman) and Mr. Chen Dawei (Vice-chairman); and three independent non-executive Directors, namely, Dr. Carl Aslan Jason Morton Firth, Mr. Zhao Zhi Gang and Mr. Chow Kai Ming.

2